Management of bipolar I depression: clinical utility of lurasidone

Lurasidone is a benzisothiazol derivative second-generation antipsychotic. It has been approved in the United States and Europe for treatment of acute schizophrenia and bipolar depression. In type I bipolar subjects, treatment with lurasidone monotherapy of adjunctive therapy to lithium or valproic...

Descripción completa

Detalles Bibliográficos
Autores principales: Findlay, Lillian Jan, El-Mallakh, Peggy, El-Mallakh, Rif S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293929/
https://www.ncbi.nlm.nih.gov/pubmed/25609973
http://dx.doi.org/10.2147/TCRM.S57695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293929/
https://www.ncbi.nlm.nih.gov/pubmed/25609973
http://dx.doi.org/10.2147/TCRM.S57695

Ejemplares similares